FDA Warning Letter — Beaute Bounty
The FDA took a Warning Letter action against Beaute Bounty on Sep 25, 2026 (Kuala Lumpur, Malaysia). The action was issued by CBER and concerns biologics products.
Action Details
- Facility
- Beaute Bounty
- Date
- Sep 25, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Center
- CBER
- Location
- Kuala Lumpur (Malaysia)